2014 Q2 Form 10-Q Financial Statement
#000114420414046085 Filed on July 31, 2014
Income Statement
| Concept | 2014 Q2 | 2013 Q2 |
|---|---|---|
| Revenue | $16.88M | $15.77M |
| YoY Change | 7.02% | -29.14% |
| Cost Of Revenue | $14.67M | $13.22M |
| YoY Change | 10.99% | 10.04% |
| Gross Profit | $2.202M | $2.548M |
| YoY Change | -13.58% | -75.11% |
| Gross Profit Margin | 13.05% | 16.16% |
| Selling, General & Admin | $1.545M | $1.774M |
| YoY Change | -12.91% | 0.34% |
| % of Gross Profit | 70.16% | 69.62% |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $200.0K | $190.0K |
| YoY Change | 5.26% | 46.15% |
| % of Gross Profit | 9.08% | 7.46% |
| Operating Expenses | $1.545M | $1.774M |
| YoY Change | -12.91% | 0.34% |
| Operating Profit | $657.0K | $774.0K |
| YoY Change | -15.12% | -90.86% |
| Interest Expense | $186.0K | $243.0K |
| YoY Change | -23.46% | 29.95% |
| % of Operating Profit | 28.31% | 31.4% |
| Other Income/Expense, Net | -$186.0K | -$243.0K |
| YoY Change | -23.46% | 30.65% |
| Pretax Income | $471.0K | $531.0K |
| YoY Change | -11.3% | -93.59% |
| Income Tax | $163.0K | $197.0K |
| % Of Pretax Income | 34.61% | 37.1% |
| Net Earnings | $308.0K | $334.0K |
| YoY Change | -7.78% | -93.5% |
| Net Earnings / Revenue | 1.83% | 2.12% |
| Basic Earnings Per Share | $0.01 | $0.01 |
| Diluted Earnings Per Share | $0.01 | $0.01 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 26.27M shares | 24.89M shares |
| Diluted Shares Outstanding | 27.85M shares | 26.86M shares |
Balance Sheet
| Concept | 2014 Q2 | 2013 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $1.900M | $2.400M |
| YoY Change | -20.83% | -40.0% |
| Cash & Equivalents | $1.893M | $2.374M |
| Short-Term Investments | ||
| Other Short-Term Assets | $3.500M | $3.200M |
| YoY Change | 9.38% | -15.79% |
| Inventory | $24.52M | $51.30M |
| Prepaid Expenses | ||
| Receivables | $10.16M | $11.87M |
| Other Receivables | $1.700M | $0.00 |
| Total Short-Term Assets | $41.82M | $68.76M |
| YoY Change | -39.18% | 40.0% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $4.422M | $4.903M |
| YoY Change | -9.81% | 31.55% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | $44.00K | $62.00K |
| YoY Change | -29.03% | -32.61% |
| Long-Term Investments | $400.0K | $1.200M |
| YoY Change | -66.67% | |
| Other Assets | $111.0K | $291.0K |
| YoY Change | -61.86% | 35.98% |
| Total Long-Term Assets | $10.04M | $9.812M |
| YoY Change | 2.33% | 143.29% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $41.82M | $68.76M |
| Total Long-Term Assets | $10.04M | $9.812M |
| Total Assets | $51.86M | $78.58M |
| YoY Change | -34.0% | 47.84% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $6.600M | $9.100M |
| YoY Change | -27.47% | -37.24% |
| Accrued Expenses | $300.0K | $300.0K |
| YoY Change | 0.0% | -57.14% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $300.0K | $24.50M |
| YoY Change | -98.78% | 353.7% |
| Total Short-Term Liabilities | $7.123M | $35.11M |
| YoY Change | -79.71% | 64.92% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $528.0K | $4.824M |
| YoY Change | -89.05% | -4.74% |
| Other Long-Term Liabilities | ||
| YoY Change | ||
| Total Long-Term Liabilities | $528.0K | $4.824M |
| YoY Change | -89.05% | -4.74% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $7.123M | $35.11M |
| Total Long-Term Liabilities | $528.0K | $4.824M |
| Total Liabilities | $7.651M | $39.93M |
| YoY Change | -80.84% | 51.54% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$16.64M | -$6.465M |
| YoY Change | 157.4% | -60.64% |
| Common Stock | $320.0K | $251.0K |
| YoY Change | 27.49% | 5.02% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $44.21M | $38.64M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $51.86M | $78.58M |
| YoY Change | -34.0% | 47.84% |
Cashflow Statement
| Concept | 2014 Q2 | 2013 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $308.0K | $334.0K |
| YoY Change | -7.78% | -93.5% |
| Depreciation, Depletion And Amortization | $200.0K | $190.0K |
| YoY Change | 5.26% | 46.15% |
| Cash From Operating Activities | $1.980M | -$6.490M |
| YoY Change | -130.51% | 360.28% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$200.0K | -$340.0K |
| YoY Change | -41.18% | -10.53% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $40.00K | $40.00K |
| YoY Change | 0.0% | |
| Cash From Investing Activities | -$160.0K | -$290.0K |
| YoY Change | -44.83% | -25.64% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -2.410M | 7.720M |
| YoY Change | -131.22% | 36.64% |
| NET CHANGE | ||
| Cash From Operating Activities | 1.980M | -6.490M |
| Cash From Investing Activities | -160.0K | -290.0K |
| Cash From Financing Activities | -2.410M | 7.720M |
| Net Change In Cash | -590.0K | 940.0K |
| YoY Change | -162.77% | -75.58% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $1.980M | -$6.490M |
| Capital Expenditures | -$200.0K | -$340.0K |
| Free Cash Flow | $2.180M | -$6.150M |
| YoY Change | -135.45% | 497.09% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
33967000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
207000 | USD |
| CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
608000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
41866000 | USD |
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Credit Risk</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company's trade accounts receivables are primarily due from companies throughout the United States. The Company reviews each customer's credit history before extending credit.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">For the six month period ended June 30, 2014, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">two customers each accounted for 10% or more of the Company’s revenues</font> and, in the aggregate these two customers accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 28</font>% of the Company’s revenues. At June 30, 2014, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,230,000</font> in outstanding receivables from these customers.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">For the six month period ended June 30, 2013, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">two customers each accounted for 10% or more of the Company’s revenues</font> and, in the aggregate these two customers accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 29</font>% of the Company’s revenues. At June 30, 2013, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1,842,000</font> in outstanding receivables from these customers.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company's products or services by any such customer could have a material adverse effect on the Company's operating results and financial position.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Estimates and Risks</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect reported amounts of certain assets and liabilities, the disclosure of contingent assets and liabilities, and the results of operations during the reporting period. Actual results could differ from these estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Several of the Company's accounting policies involve significant judgments, uncertainties and estimations. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The Company participates in an industry that is highly regulated, and changes in the regulations affecting our business could affect our operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the “Act”) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants. Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants and which imposed limitations on the importation of certain virgin HCFC refrigerants. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by 2030. In December 2009, the Environmental Protection Agency (“EPA”) issued a final rule (the “2009 Rule”) which limited the total pounds of virgin HCFC refrigerants that could be produced and imported for the years 2010 through 2014 to levels which, based upon the EPA’s estimates, would require as much as 20% of the service demand for existing equipment to be met by reclaimed or recycled HCFC refrigerants. As a result of litigation, the 2009 Rule was vacated, and in April 2013, the EPA issued a final rule (the “April 2013 Rule”) providing for further reductions in the production and importation of HCFC refrigerants in the years 2013 and 2014 when compared to the reductions originally established in the 2009 Rule. In December 2013, a proposed rule was issued by the EPA to address production and consumption allowances for HCFC refrigerants for the years 2015 through 2019. In the proposed rule, the EPA discusses several alternatives for the phase down of HCFC-22 during the years 2015 through 2019, and identifies a preferred approach that would implement a linear draw down for the production or importation of HCFC-22 that would start at <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30</font> million pounds in 2015 and reduce by approximately 6 million pounds each year and end at zero in 2020. A final rule to address production and consumption allowances for the years 2015 through 2019 has not yet been issued by the EPA. The Company expects that a final rule establishing the actual number of pounds for the years 2015 through 2019 will be issued late in 2014.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
| us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1641000 | USD | |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
27846672 | shares |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
26859009 | shares |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
| CY2014Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
32031426 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
25070386 | shares |
| CY2014Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
32031426 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
25070386 | shares |
| CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
106000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
5363000 | USD |
| CY2014Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
44000 | USD |
| CY2014Q2 | us-gaap |
Assets
Assets
|
51862000 | USD |
| CY2014Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6558000 | USD |
| CY2014Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
287000 | USD |
| CY2014Q2 | us-gaap |
Debt Current
DebtCurrent
|
278000 | USD |
| CY2014Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7123000 | USD |
| CY2014Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
528000 | USD |
| CY2014Q2 | us-gaap |
Liabilities
Liabilities
|
7651000 | USD |
| CY2014Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
320000 | USD |
| CY2014Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
60532000 | USD |
| CY2014Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-16641000 | USD |
| CY2014Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
44211000 | USD |
| CY2014Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
51862000 | USD |
| hdsn |
Earnings Before Interest Taxes Depreciation And Amortization Income Tax Expense Benefit
EarningsBeforeInterestTaxesDepreciationAndAmortizationIncomeTaxExpenseBenefit
|
-261000 | USD | |
| hdsn |
Earnings Before Interest Taxes Depreciation And Amortization Income Loss Before Income Taxes
EarningsBeforeInterestTaxesDepreciationAndAmortizationIncomeLossBeforeIncomeTaxes
|
729000 | USD | |
| hdsn |
Earnings Before Interest Taxes Depreciation And Amortization Interest Expense
EarningsBeforeInterestTaxesDepreciationAndAmortizationInterestExpense
|
-395000 | USD | |
| hdsn |
Earnings Before Interest Taxes Depreciation And Amortization Adjustments
EarningsBeforeInterestTaxesDepreciationAndAmortizationAdjustments
|
-411000 | USD | |
| hdsn |
Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
|
1535000 | USD | |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
36268000 | USD | |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
29666000 | USD | |
| us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
2377000 | USD | |
| us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
2793000 | USD | |
| us-gaap |
Revenues
Revenues
|
38645000 | USD | |
| us-gaap |
Revenues
Revenues
|
32459000 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
4803000 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
468000 | USD | |
| CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
334000 | USD |
| CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
308000 | USD |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | ||
| CY2014Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1893000 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
669000 | USD |
| CY2014Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
10163000 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
3706000 | USD |
| CY2014Q2 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
1699000 | USD |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
24605541 | shares | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
25679066 | shares | |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
24891115 | shares |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
26267746 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
26670232 | shares | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
27357936 | shares | |
| dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
1991-01-11 | ||
| us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.29 | pure | |
| us-gaap |
Concentration Risk Percentage1
ConcentrationRiskPercentage1
|
0.28 | pure | |
| CY2014Q2 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
5294000 | USD |
| CY2013Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
5570000 | USD |
| us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
Approximately $10,600,000 of the Companys $16,000,000 of NOLs are subject to annual limitations of $1,300,000. | ||
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
50000 | shares | |
| us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
80843 | shares | |
| CY2013Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
50000 | shares |
| CY2014Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
80843 | shares |
| hdsn |
Production And Importation Permission From Government Agency
ProductionAndImportationPermissionFromGovernmentAgency
|
30000000 | lb | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0085 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0169 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.76 | pure | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.59 | pure | |
| CY2013Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
2709000 | USD |
| CY2014Q2 | us-gaap |
Inventory Net
InventoryNet
|
24517000 | USD |
| CY2014Q2 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
207000 | USD |
| CY2014Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3342000 | USD |
| CY2014Q2 | us-gaap |
Assets Current
AssetsCurrent
|
41821000 | USD |
| CY2014Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4422000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4536000 | USD |
| CY2014Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
111000 | USD |
| CY2014Q2 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
5087000 | USD |
| CY2014Q2 | us-gaap |
Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
|
377000 | USD |
| CY2013Q4 | us-gaap |
Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
|
440000 | USD |
| CY2013Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
57000 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
52368000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
3955000 | USD |
| CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
289000 | USD |
| CY2013Q4 | us-gaap |
Debt Current
DebtCurrent
|
15367000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
19611000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
4671000 | USD |
| CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
24282000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
251000 | USD |
| CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
44944000 | USD |
| CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-17109000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
28086000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
52368000 | USD |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
4003861 | USD |
| hdsn |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue
|
0 | USD | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
52000 | USD | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
33000 | USD | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
18000 | USD | |
| CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
5500000 | shares |
| CY2014Q2 | us-gaap |
Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
|
2511733 | shares |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P2Y | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
50000 | shares | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
10000 | shares | |
| CY2014Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
79000 | USD |
| CY2013Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
2816000 | USD |
| hdsn |
Earnings Before Interest Taxes Depreciation And Amortization Net Income Loss
EarningsBeforeInterestTaxesDepreciationAndAmortizationNetIncomeLoss
|
468000 | USD | |
| CY2013Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
40000000 | USD |
| CY2012Q2 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
27000000 | USD |
| CY2014Q2 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
125000 | USD |
| CY2014Q2 | us-gaap |
Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
|
24000000 | USD |
| CY2014Q2 | us-gaap |
Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
|
0.030 | pure |
| us-gaap |
Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
|
Interest charges with respect to loans are computed on the actual principal amount of loans outstanding during the month at a rate per annum equal to (A) with respect to domestic rate loans, the sum of (i) a rate per annum equal to the higher of (1) the base commercial lending rate of PNC, (2) the federal funds open rate plus .5% and (3) the daily LIBOR plus 1%, plus (ii) .5% and (B) with respect to Eurodollar rate loans, the sum of the Eurodollar rate plus 2.75%. | ||
| hdsn |
Production And Importation Permission From Government Agency
ProductionAndImportationPermissionFromGovernmentAgency
|
63000000 | lb | |
| CY2014Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q2 | us-gaap |
Revenues
Revenues
|
15768000 | USD |
| CY2014Q2 | us-gaap |
Revenues
Revenues
|
16875000 | USD |
| us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
26935000 | USD | |
| us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
28454000 | USD | |
| CY2013Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
13220000 | USD |
| CY2014Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
14673000 | USD |
| us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1085000 | USD | |
| us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD | |
| us-gaap |
Gross Profit
GrossProfit
|
11710000 | USD | |
| us-gaap |
Gross Profit
GrossProfit
|
4005000 | USD | |
| CY2013Q2 | us-gaap |
Gross Profit
GrossProfit
|
2548000 | USD |
| CY2014Q2 | us-gaap |
Gross Profit
GrossProfit
|
2202000 | USD |
| us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1264000 | USD | |
| CY2013Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
818000 | USD |
| CY2014Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
614000 | USD |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1890000 | USD | |
| us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1617000 | USD | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
497000 | USD | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
276000 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
9933000 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
6457000 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
11131000 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-9450000 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2305000 | USD | |
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2789000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2517000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2601000 | USD | |
| CY2013Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
956000 | USD |
| CY2014Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
931000 | USD |
| us-gaap |
Operating Expenses
OperatingExpenses
|
3531000 | USD | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
2881000 | USD | |
| CY2013Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
1774000 | USD |
| CY2014Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
1545000 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
8179000 | USD | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1124000 | USD | |
| CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
774000 | USD |
| CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
657000 | USD |
| us-gaap |
Interest Expense
InterestExpense
|
440000 | USD | |
| us-gaap |
Interest Expense
InterestExpense
|
395000 | USD | |
| CY2013Q2 | us-gaap |
Interest Expense
InterestExpense
|
243000 | USD |
| CY2014Q2 | us-gaap |
Interest Expense
InterestExpense
|
186000 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
7739000 | USD | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
729000 | USD | |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
531000 | USD |
| CY2014Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
471000 | USD |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2936000 | USD | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
261000 | USD | |
| CY2013Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
197000 | USD |
| CY2014Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
163000 | USD |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.20 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.02 | ||
| CY2013Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | |
| CY2014Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.18 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.02 | ||
| CY2013Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.01 | |
| CY2014Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.01 | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
388000 | USD | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
411000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
33000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
18000 | USD | |
| us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
41000 | USD | |
| us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
50000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-13830000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
5038000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
513000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
284000 | USD | |
| us-gaap |
Investments In And Advances To Affiliates At Fair Value Period Increase Decrease
InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease
|
-27000 | USD | |
| us-gaap |
Investments In And Advances To Affiliates At Fair Value Period Increase Decrease
InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease
|
63000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-540000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-221000 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1110000 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
15639000 | USD | |
| us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
11736000 | USD | |
| us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
-15089000 | USD | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
93000 | USD | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
4143000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
12753000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3593000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-1617000 | USD | |
| us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1224000 | USD | |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3991000 | USD |
| CY2013Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2374000 | USD |
| us-gaap |
Interest Paid
InterestPaid
|
399000 | USD | |
| us-gaap |
Interest Paid
InterestPaid
|
345000 | USD | |
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-06-30 | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
| dei |
Entity Registrant Name
EntityRegistrantName
|
HUDSON TECHNOLOGIES INC /NY | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000925528 | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | ||
| dei |
Trading Symbol
TradingSymbol
|
HDSN | ||
| CY2014Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
32031426 | shares |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-440000 | USD | |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-395000 | USD | |
| CY2013Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-243000 | USD |
| CY2014Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-186000 | USD |
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
23000 | USD | |
| us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | USD | |
| us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
0 | USD | |
| us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
-1010000 | USD | |
| us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
1237000 | USD | |
| us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
0 | USD | |
| hdsn |
Production And Importation Permission Description
ProductionAndImportationPermissionDescription
|
30 million pounds in 2015 and reduce by approximately 6 million pounds each year and end at zero in 2020. | ||
| us-gaap |
Concentration Risk Customer
ConcentrationRiskCustomer
|
two customers each accounted for 10% or more of the Company’s revenues | ||
| us-gaap |
Concentration Risk Customer
ConcentrationRiskCustomer
|
two customers each accounted for 10% or more of the Company’s revenues | ||
| CY2014Q2 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
6900000 | shares |
| CY2014Q2 | us-gaap |
Share Price
SharePrice
|
2.3375 | |
| CY2014Q2 | hdsn |
Purchase Of Additional Common Stock
PurchaseOfAdditionalCommonStock
|
900000 | shares |
| CY2014Q2 | hdsn |
Reimbursement Expense
ReimbursementExpense
|
150000 | USD |
| CY2014Q2 | hdsn |
Additional Offering Expenses
AdditionalOfferingExpenses
|
400000 | USD |
